Replies to post #62733 on Biotech Values

[emserm]

Tinker,

I do agree with your statement about the last Conference Call - There was not much said about Porve III or if they will even try to file for an early approval - MIchael Patridge did not say much at all, but I urge you to listen to the Conference Call from Ian Smith CFO from May 5th at the Deutsche Bank - http://investors.vrtx.com/events.cfm

You will get a whole different feeling about early approval.

I hope that the next one of May 22nd will be done by Ian Smith again.

Let me know what your thoughts are,

Thanks,

emserm